-
Understand the definition of febrile neutropenia in patients receiving chemotherapy
-
Appreciate the impact both for the patient and the health system
-
Be familiar with risk assessment for the development of serious complications
-
Know the treatment options
About This Course
Managing chemotherapy-induced neutropenia in 2021 - get the latest updates to improve treatment adherence, increase patient access, and reduce clinic visits during the COVID-19 pandemic.
An interactive course aimed at healthcare professionals (oncologists, general practitioners, nurse practitioners) treating cancer patients receiving chemotherapy.
This course should take you approximately 60 minutes to complete.
Developed together with world-leading experts:
Lee Schwartzberg, MD FACP
West Cancer Center, Germantown, TN, USA
Adam Brufsky, MD PhD
University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
Kashyap B Patel, MD
Carolina Blood and Cancer Care Associates, Rock Hill, SC, USA
This course has a 2-year expiry date of 15th May 2025. If you complete this course after its expiry date, please double check all claims in this course with up-to-date, peer-reviewed information, as the diagnostic or treatment landscape may have changed.
Learning Objectives
By the end of this module, you should:
Course curriculum
-
-
Welcome to the Course
-
-
-
Navigation Instructions
-
-
-
Take this quiz before you start
-
Pre-Course Quiz
-
-
-
Main Course
-
-
-
Introduction to Final Quiz
-
Now check how much you have learned.
-
-
-
Download the summary sheet
-
-
-
Course Feedback Survey
-

About this course
- Free
- 9 lessons
- 0 hours of video content
Commercial Support
This activity is supported by an educational grant from Fresenius Kabi SwissBioSim GmbH.
